Premium
Facial hemihypertrophy in a girl with sturge‐weber syndrome: Treatment with oral sirolimus
Author(s) -
Giacaman Aniza,
Salinas Sanz José Antonio,
Navarro Noguera Samuel,
Lastra Rodríguez Juan,
Montis Palos María Concepción,
MartínSantiago Ana
Publication year - 2021
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.14520
Subject(s) - medicine , sirolimus , sturge–weber syndrome , hemihypertrophy , dermatology , girl , surgery , psychology , developmental psychology
In the last few years, the use of oral sirolimus has shown promising results in the treatment of some complex vascular anomalies, and recently, it has been used in patients with Sturge‐Weber syndrome (SWS). We present the case of an 11‐year‐old girl with the diagnosis of SWS and hemifacial overgrowth treated with oral sirolimus. Throughout the eight months of follow‐up, improvement of the port‐wine birthmark, intraocular pressure, and neurocognitive development was noted. The mTOR inhibitors may be useful in the treatment of some patients with SWS.